These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9678607)

  • 1. Insights into the structure of hepatocyte growth factor/scatter factor (HGF/SF) and implications for receptor activation.
    Chirgadze DY; Hepple J; Byrd RA; Sowdhamini R; Blundell TL; Gherardi E
    FEBS Lett; 1998 Jun; 430(1-2):126-9. PubMed ID: 9678607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domain structure of hepatocyte growth factor/scatter factor (HGF/SF).
    Gherardi E; Hartmann G; Hepple J; Chirgadze D; Srinivasan N; Blundell T
    Ciba Found Symp; 1997; 212():84-93; discussion 93-104. PubMed ID: 9524765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
    Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
    Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
    Mizuno K; Inoue H; Hagiya M; Shimizu S; Nose T; Shimohigashi Y; Nakamura T
    J Biol Chem; 1994 Jan; 269(2):1131-6. PubMed ID: 8288571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.
    Lietha D; Chirgadze DY; Mulloy B; Blundell TL; Gherardi E
    EMBO J; 2001 Oct; 20(20):5543-55. PubMed ID: 11597998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.
    Holmes O; Pillozzi S; Deakin JA; Carafoli F; Kemp L; Butler PJ; Lyon M; Gherardi E
    J Mol Biol; 2007 Mar; 367(2):395-408. PubMed ID: 17258232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution.
    Ultsch M; Lokker NA; Godowski PJ; de Vos AM
    Structure; 1998 Nov; 6(11):1383-93. PubMed ID: 9817840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
    Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa.
    Pediaditakis P; Monga SP; Mars WM; Michalopoulos GK
    J Biol Chem; 2002 Apr; 277(16):14109-15. PubMed ID: 11832492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding.
    Chirgadze DY; Hepple JP; Zhou H; Byrd RA; Blundell TL; Gherardi E
    Nat Struct Biol; 1999 Jan; 6(1):72-9. PubMed ID: 9886295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis.
    Montesano R; Soriano JV; Malinda KM; Ponce ML; Bafico A; Kleinman HK; Bottaro DP; Aaronson SA
    Cell Growth Differ; 1998 May; 9(5):355-65. PubMed ID: 9607557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for agonism and antagonism of hepatocyte growth factor.
    Tolbert WD; Daugherty-Holtrop J; Gherardi E; Vande Woude G; Xu HE
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13264-9. PubMed ID: 20624990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.
    Gherardi E; Youles ME; Miguel RN; Blundell TL; Iamele L; Gough J; Bandyopadhyay A; Hartmann G; Butler PJ
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12039-44. PubMed ID: 14528000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
    Gherardi E; Sandin S; Petoukhov MV; Finch J; Youles ME; Ofverstedt LG; Miguel RN; Blundell TL; Vande Woude GF; Skoglund U; Svergun DI
    Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4046-51. PubMed ID: 16537482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor.
    Lokker NA; Presta LG; Godowski PJ
    Protein Eng; 1994 Jul; 7(7):895-903. PubMed ID: 7971951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
    Sakata H; Stahl SJ; Taylor WG; Rosenberg JM; Sakaguchi K; Wingfield PT; Rubin JS
    J Biol Chem; 1997 Apr; 272(14):9457-63. PubMed ID: 9083085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis.
    Hartmann G; Naldini L; Weidner KM; Sachs M; Vigna E; Comoglio PM; Birchmeier W
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11574-8. PubMed ID: 1280830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
    Niemann HH
    Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
    Bardelli A; Ponzetto C; Comoglio PM
    J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist.
    Youles M; Holmes O; Petoukhov MV; Nessen MA; Stivala S; Svergun DI; Gherardi E
    J Mol Biol; 2008 Mar; 377(3):616-22. PubMed ID: 18291418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.